Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients
about
Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapyHematopoietic stem cell gene therapy:assessing the relevance of preclinical modelsThe new stem cell biology: something for everyone.Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma -chain and multidrug resistance (MDR1) transgenes in canine bone marrow.Knockdown of HPRT for selection of genetically modified human hematopoietic progenitor cellsGenetic modification of human hematopoietic cells: preclinical optimization of oncoretroviral-mediated gene transfer for clinical trialsGene therapy of benign gynecological diseases.Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes.Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression.Survival of the fittest: in vivo selection and stem cell gene therapyAmelioration of murine beta-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both gamma-globin and the MGMT drug-resistance gene.Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).Stem cell technology. Interview by Abi Berger
P2860
Q26771159-DE2F5F99-B27C-4B3C-950A-1B97B0178FA1Q26859147-64E5EF0B-3B5E-404C-8624-FEAF145019B8Q33919141-C79A4664-8560-4D02-8A94-8A8BBD31AFCFQ34016586-04A0C874-A7CD-497D-AB57-DAB5FC3038AFQ34649263-02447BFA-A85B-4426-9E9D-ABF8463D340AQ35180417-F153B9B0-4724-41D5-89FC-4BC64FE2E8B5Q35770271-5D7A4E33-D09E-4069-8FE4-93CCC54F8A34Q35847830-CFCE405F-4C7F-4C49-93A1-C129B28CB3FEQ35990723-A8F3230B-18C7-49A3-9659-41896C789C05Q36306141-D3CBE6FA-F506-453D-B583-780B3879A2D9Q37237435-7BAF770F-5416-4C5A-83DC-1E5DA9AB3F5AQ38088242-8BE4BA16-695C-4C2A-8FA5-27E741AEE332Q40228003-26A79D92-41B1-4B61-965A-66BAD12FB40CQ42126220-A8337F79-3074-4BD5-B677-9AE9A8B23FDB
P2860
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@ast
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@en
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@nl
type
label
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@ast
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@en
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@nl
prefLabel
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@ast
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@en
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@nl
P2093
P1476
Paclitaxel chemotherapy after ...... astatic breast cancer patients
@en
P2093
A Nienhuis
B Goldspiel
B Sorrentino
E Schneider
P304
P407
P577
1999-07-01T00:00:00Z